Global Erectile Dysfunction Drugs Market Research Report 2023 and 2024-2034: Regulatory Approvals Boost Market Prospects, Viagra Dominates, Research and Development Activities Surge Dublin, Jan. 15, 2024 (GLOBE NEWSWIRE) -- The "Global Erectile Dysfunction Drugs Market Analysis & Forecast to 2024-2034" report has been added to ResearchAndMarkets.com's offering. The...

Erectile Dysfunction (ED) Drugs Market is expected to register a -3.1% CAGR, reaching a Valuation of US$ 2.5 billion by 2028: TMR Report Wilmington, Delaware, United States, July 03, 2023 (GLOBE NEWSWIRE) -- The global erectile dysfunction (ED) drugs market to reach the value of US$ 2.5 Bn by 2028 with CAGR of -3.1. This outlook is...

Global $4.7 Billion Erectile Dysfunction Market Outlook and Forecast 2021-2026: Major Players are Eli Lilly and Co, VIVUS, Pfizer, Bayer, Boston Scientific, Coloplast, Teva, Viatris, Dong-A Socio Dublin, Feb. 23, 2021 (GLOBE NEWSWIRE) -- The "Erectile Dysfunction Market - Global Outlook and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering. The global erectile...

Premature Ejaculation (PE) Therapeutics Market Outlook, 2025 - High Demand for Topical Drug Therapies for PE Treatment Dublin, Aug. 28, 2020 (GLOBE NEWSWIRE) -- The "Premature Ejaculation Therapeutics Market - Global Outlook and Forecast 2020-2025" report has been added to ResearchAndMarkets.com's offering.Get an...

DRGT Announces the U.S. FDA IND Application Approval and First Dosing of a Clinical Trial to Evaluate the Bioavailability and Food Effect of Immediate-Release Formulation of Tadalafil (DRGT-99) BUDAPEST, Hungary, Sept. 18, 2019 (GLOBE NEWSWIRE) -- Druggability Technologies Holdings (DRGT) today announces that the U.S. Food and Drug Administration (FDA) has approved its Investigational New...